The global Dyslexia Treatments Market was worth US$ 4.1 Billion in the year 2022 and is expected to reach US$ 8.06 Billion by the year 2032 at a CAGR of 6.3% between 2022 and 2032.
Improper and slow recognition of words signifies dyslexia. As per Dyslexia Center of Utah, 70-80% of the ones with weaker reading skills are categorized as dyslexic. It’s amongst the malfunctioning of neurodevelopmental conditions. Research states that 10% of people all over contract dyslexia. Early detection renders it simple to combat the challenges brought through the disorder.
Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5281
At the same time, the fact that there isn’t much awareness with regards to learning impairments, underdiagnoses, and symptoms can’t be ignored. Specialization in testing accommodations like taking notes in class and more time for homework could be imperative for the dyslexic children. If not detected on time, the situation may get out of control. These factors may restrain the Dyslexia Treatments market going forward.
Future Market Insights has entailed these facets with future prospects in its latest market study entitled ‘Dyslexia Treatments Market’. It has its team of analysts and consultants to look through bottom-up approach in its primary, secondary, and tertiary modes of research.
“Benevolence regarding dyslexia is expected to drive the Dyslexia Treatments market in the forecast period”, says an analyst from Future Market Insights.
Key Takeaways from Dyslexia Treatments Market
- North America holds more than 40% of the market share. This could be credited to continuous development of medical services’ framework, conducive government policies, and presence of organizations like Speechify (US) and Jubilant Cadista (US) to create awareness. Moreover, as per MIT’s neuroscientists, 5-15% of Americans suffer from dyslexia. It has also been found that students suffering from learning disabilities end up dropping out of the high schools twice as the other students. This data was released by the National Centre for Education Statistics.
- Europe holds the second-largest market share. It holds more than 20% of the overall market share. Coming to innovations, Norway-based Lingit was recently bought by Verdane Capital. This software, in the text-processing apps for tablets and computers, does help a person with vocabulary, reading, and spelling.
- The Asia-Pacific is expected to grow at the quickest rate in the Dyslexia Treatments market in the forecast period. This could be credited to digital transformation witnessed by the educational sector in India and China.
To remain ‘ahead’ of your competitors, Ask a Question@ https://www.futuremarketinsights.com/ask-question/rep-gb-5281
Competitive Analysis
- Intra-Cellular Therapies, Inc., in December 2021, did announce that the US FDA designated CAPLYTA to catch depressive incidents pertaining to bipolar I or II disorder in adults as monotherapy or adjunctive therapy with valproate or lithium.
- Microsoft, in February 2022, along with the ‘Made by Dyslexia’ global community of dyslexics collaborated for creating a dyslexia training curriculum to help teachers in empowering dyslexic students.
- Understood, in February 2022, created a novel digital newsprint. Understood comes across as a social impact NGO supporting people with dyslexia and ADHD. It does highlight stores and experiences that come solely from the neurodivergent folks.
- Andre Agassi, in March 2020, unleashed a novel initiative with Square Panda (an ed-tec start-up) for developing the very first universally free dyslexia assessment game with a recognized phonics learning program helping children since the age of 2 and above in developing reading and cognitive skills.
- AIIMS (All India Institute of Medical Sciences), in December 2022, did announce developing an app for helping in curing dyslexia in the children. The app has been made under ‘AIIMS Pediatric Neurology Dyslexia Remedial Intervention Program’ having 8 modules that let dyslexia treatment happen at home.
Key Players
- The Himmel Group
- DK Pharmachem
- Pfizer Inc
- RPG Life Sciences Ltd
- Wallace Pharmaceuticals Ltd
- Cian Healthcare Pvt. Ltd
- Rhodes Pharmaceuticals L.P.
- Purdue Pharma
- Apotex Corporation
- Unither Pharmaceuticals
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/5281
Key Segments Covered in the Dyslexia Treatments Industry Survey
Dyslexia Treatments Market by Drug Type:
- Cyclizine-based Dyslexia Treatment
- Meclizine-based Dyslexia Treatment
- Dimenhydrinate-based Dyslexia Treatment
- Methylphenidate-based Dyslexia Treatment
Dyslexia Treatments Market by Distribution Channel:
- Dyslexia Treatment via Hospital Pharmacies
- Dyslexia Treatment via Retail Pharmacies
- Dyslexia Treatment via Online Pharmacies
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
